Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 2:14 pm Sale | 13G | ESPERION THERAPEUTICS INC ESPR | CVI Investments Inc. | 0 0% | -5,500,000 (Position Closed) | View |
| 2024-02-14 10:50 am Sale | 13G | ESPERION THERAPEUTICS INC ESPR | Two Seas Capital LP | 7,686,120 6.8% | -236,050 (-2.98%) | View |
| 2024-02-14 08:42 am Sale | 13G | ESPERION THERAPEUTICS INC ESPR | Deep Track Capital LP | 0 0% | -6,345,790 (Position Closed) | View |
| 2024-02-14 06:11 am Sale | 13G | ESPERION THERAPEUTICS INC ESPR | Point72 Asset Management L.P. | 209,971 0.2% | -4,323,785 (-95.37%) | View |
| 2024-02-13 5:04 pm Purchase | 13G | ESPERION THERAPEUTICS INC ESPR | VANGUARD GROUP INC | 5,137,750 4.52% | 877,286 (+20.59%) | View |
| 2024-02-09 4:14 pm Purchase | 13G | ESPERION THERAPEUTICS INC ESPR | WASATCH ADVISORS LP | 15,163,886 12.6% | 5,362,725 (+54.72%) | View |
| 2024-01-24 3:46 pm Purchase | 13G | ESPERION THERAPEUTICS INC ESPR | BB BIOTECH AG | 9,194,064 5.1% | 5,000,000 (+119.22%) | View |
| 2024-01-24 3:21 pm Unchanged | 13G | ESPERION THERAPEUTICS INC ESPR | BB BIOTECH AG | 4,194,064 3.7% | 0 (Unchanged) | View |
| 2024-01-17 5:01 pm Sale | 13G | ESPERION THERAPEUTICS INC ESPR | MILLENNIUM MANAGEMENT LLC | 3,643,951 3.2% | -1,722,501 (-32.10%) | View |
| 2024-01-03 11:02 am Sale | 13G | ESPERION THERAPEUTICS INC ESPR | Meditor Group Ltd | 3,791,300 3.3% | -677,535 (-15.16%) | View |
| 2023-10-05 09:00 am Purchase | 13G | ESPERION THERAPEUTICS INC ESPR | Two Seas Capital LP | 7,922,170 7.4% | 7,922,170 (New Position) | View |
| 2023-08-29 4:17 pm Purchase | 13G | ESPERION THERAPEUTICS INC ESPR | MILLENNIUM MANAGEMENT LLC | 5,366,452 5% | 143,013 (+2.74%) | View |
| 2023-08-28 4:13 pm Purchase | 13G | ESPERION THERAPEUTICS INC ESPR | MILLENNIUM MANAGEMENT LLC | 5,223,439 4.9% | 1,599,537 (+44.14%) | View |
| 2023-06-08 1:25 pm Sale | 13G | ESPERION THERAPEUTICS INC ESPR | BlackRock Inc. BLK | 4,645,359 4.9% | -863,828 (-15.68%) | View |
| 2023-04-05 4:23 pm Purchase | 13G | ESPERION THERAPEUTICS INC ESPR | Point72 Asset Management L.P. | 4,533,756 5% | 2,095,618 (+85.95%) | View |
| 2023-02-14 4:18 pm Sale | 13G | ESPERION THERAPEUTICS INC ESPR | BB BIOTECH AG | 4,194,064 5.7% | -283,900 (-6.34%) | View |
| 2023-02-14 4:14 pm Sale | 13G | ESPERION THERAPEUTICS INC ESPR | Point72 Asset Management L.P. | 2,438,138 4.2% | -1,032,140 (-29.74%) | View |
| 2023-02-14 11:14 am Sale | 13G | ESPERION THERAPEUTICS INC ESPR | CVI Investments Inc. | 5,500,000 6.9% | -1,222,709 (-18.19%) | View |
| 2023-02-10 1:46 pm Purchase | 13G | ESPERION THERAPEUTICS INC ESPR | WASATCH ADVISORS LP | 9,801,161 12.8% | 462,115 (+4.95%) | View |
| 2023-02-09 11:19 am Purchase | 13G | ESPERION THERAPEUTICS INC ESPR | VANGUARD GROUP INC | 4,260,464 5.78% | 499,025 (+13.27%) | View |